• 1
    North-Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988; 319: 983989.
  • 2
    D'Amico G, Pagliaro L, Bosch J. Pharmacologic treatment of portal hypertension: an evidence-based approach. Sem Liver Dis 1999; 19: 475505.
  • 3
    D'Amico G, de Franchis R, and a cooperative study group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. HEPATOLOGY 2003; 38: 599612.
  • 4
    Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653659.
    Direct Link:
  • 5
    Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. HEPATOLOGY 2004; 40: 652659.
  • 6
    de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996; 25: 390394.
  • 7
    de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846852.
  • 8
    Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 10561059.
  • 9
    Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 1997; 26: 312324.
  • 10
    Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. HEPATOLOGY 1997: 25: 6370.
  • 11
    Bolognesi M, Balducci G, Garcia-Tsao G, Gatta A, Ginès P, Merli M, et al. Complications of the medical treatment of portal hypertension. In: de FranchisR, ed. Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science, 2001: 180201.
  • 12
    Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. HEPATOLOGY 2001; 33: 802807.
  • 13
    Chen CY, Sheu MZ, Su SY. Prophylactic endoscopic variceal ligation (EVL) with multiple band ligator for esophageal varices [Abstract]. Gastroenterology 1998; 114( Suppl): A1224.
  • 14
    Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340: 988993.
  • 15
    De BK, Ghoshal UK, Das T, Santra A, Biswas PK. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 1999; 14: 220224.
  • 16
    Song IH, Shin JW, Kim IH, Choi J, Lin CY, Kim JW, et al. A prospective randomized trial between the prophylactic endoscopic variceal ligation and propranolol administration for prevention of first bleeding in cirrhotic patients with high-risk esophageal varices [Abstract]. J Hepatol 2000; 32( Suppl 2): 41.
  • 17
    De la Mora JD, Farca-Belsaguy, Uribe M, de Hoyos-Garza A. Ligation vs. propranolol for primary prophylaxis of variceal bleeding using a multiple band ligator and objective measurements of treatment adequacy: preliminary results [Abstract]. Gastroenterology 2000; 118: A1434.
  • 18
    Psilopoulos DI, Mavrogiannis C, Vafiadis I, Dourakis S, Papanicolau SI, Alexopolou A, et al. A randomized controlled trial comparing endoscopic variceal ligation with propranolol for primary prevention of variceal bleeding (preliminary report). Gastrointestinal Endoscopy 2002; 55: ab196.
  • 19
    Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, et al. Primary prophylaxis of variceal hemorrhage : a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002; 123: 735744.
  • 20
    Gheorghe C, Gheorghe L, Vadan R, Hrehoret D, Popescu I. Prophylactic banding ligation of high risk esophageal varices in patients on the waiting list for liver transplantation: an interim analysis [Abstract]. J Hepatol 2002; 36( Suppl 1): 38.
  • 21
    Lo GH, Chen WC, Chen MS, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointestinal Endoscopy 2004; 59: 333338.
  • 22
    Schepke M, Goebel C, Nuernberg D, Willert J, Koch L, Sauerbruch T. Endoscopic banding ligation versus propranolol for the primary prevention of variceal bleeding in cirrhosis: a randomized controlled multicenter trial. HEPATOLOGY 2004; 40: 6572.
  • 23
    Jutabha R, Jensen DM, Martin P, Savides TJ, Han SH, Gornbein J Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology 2005; 128: 870881.
  • 24
    Thuluvath PJ, Maheshwari A, Jagannath S, Arepally A A randomized controlled trial of β-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci 2005; 50: 407410.
  • 25
    Drastich P, Lata J, Petryl J, Prochazka V, Vanasek T, Zdenek P, et al. Endoscopic variceal band ligation in comparison with propranolol in prophylaxis of first variceal bleeding in patients with liver cirrhosis [Abstract]. J Hepatol 2005; 42:( Suppl 2): 79.
  • 26
    Khuroo MS, Khuroo NS, Farahat KLC, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005; 21: 347361.
  • 27
    Abraczinskas DR, Ookubo R, Grace ND, Groszmann RJ, Bosch J, Garcia-Tsao G, et al. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? HEPATOLOGY 2001; 34: 10961102.
  • 28
    Spiegel BMR, Targowik L, Dulai GS, Karsan HA, Gralnek IM. Endoscopic screening for esophageal varices: is it ever cost effective? HEPATOLOGY 2003; 37: 366377.
  • 29
    de Franchis R, on behalf of the Baveno IV Chairpersons and panellists. Evolving consensus in portal hypertension. Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in Portal Hypertension. J Hepatol 2005; 43: 167176.
  • 30
    Triantos C, Vlachogiannakos J, Manolakopoulos S, Burroughs AK, Avgerinos A. Is banding ligation for primary prevention of variceal bleeding as effective as beta-blockers, and is it safe? [Letter] HEPATOLOGY 2006; 43: 196197.
  • 31
    Jensen DM. Outcomes, effectiveness, tolerability, and direct costs of prophylactic variceal treatments [Letter]. HEPATOLOGY 2006; 43: 197198.
  • 32
    Triantos C, Vlachogiannakos J, Armonis A, Saveriadis A, Kougioumtzian A, Leandro G, Manolakopoulos S, Tzourmakliotis D, Raptis SA, Burroughs AK, Avgerinos A. Primary prophylaxis of variceal bleeding in cirrhotics unable to take β-blockers: a randomized trial of ligation. Aliment Pharmacol Ther 2005; 21: 14351443.
  • 33
    Montori VM, Devereaux PJ, Adhikari NK, Burns KEA, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit. A systematic review. JAMA 2005; 294: 22032209.
  • 34
    Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?” Lancet 2005; 365: 8293.